CDT Equity Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) covers events occurring between July 31, 2026, and August 3, 2026, for CDT Equity Inc. (CDT), a Delaware corporation trading on The Nasdaq Stock Market. The filing details a series of amendments to a senior secured convertible promissory note with J.J. Astor & Co., significantly altering the company's debt obligations and equity conversion terms.
Key Financial Metrics and Debt Structure
The filing focuses on debt restructuring rather than operational financial performance. Key metrics regarding the amended debt instrument include:
- Outstanding Principal: Increased to $2,536,650 following a $200,000 advance under the Third Amendment.
- Interest Rate: Set at 19% pursuant to the Second Amendment.
- Repayment Terms: Payable in 23 equal weekly installments of $104,187.65, commencing August 19, 2026.
- Liquidity Source: Weekly installments are to be funded by increasing the net proceeds from the Company's Sales Agreement with A.G.P. from 80% to 90%.
- Equity Issuance: The Company issued warrants to purchase 37,500 shares at $7.20 per share.
The filing text does not provide clear values for revenue, net profit, operating cash flow, or overall liquidity positions outside of the specific loan mechanics described.
Material Changes Versus Prior Period
Significant modifications were made to the original and previously amended loan agreements:
- Principal Increase: The principal amount was raised from $1,971,000 (original) to $2,266,650 (Second Amendment) and finally to $2,536,650 (Third Amendment).
- Conversion Price Adjustment: The conversion price for the note was lowered to the greater of (i) 70% of the lowest VWAP over 20 trading days (previously 90% over 10 days) or (ii) the Nasdaq floor price.
- Floor Price Definition: The "Floor Price" definition was adjusted to 20% of the lowest VWAP over 20 consecutive trading days, with adjustments occurring every six months starting December 11, 2026.
- Timeline Acceleration: Deadlines for filing a resale registration statement (effective by September 11, 2026) and obtaining stockholder approval (by August 28, 2026) were advanced.
Outlook, Risks, and Contingencies
Management commentary is limited to the disclosure of the amended terms. Key risks and contingencies include:
- Stockholder Approval Requirement: Issuance of Conversion Shares and Warrant Shares exceeding 19.99% of outstanding common stock requires stockholder approval under Nasdaq rules.
- Registration Obligations: The Company must file a resale registration statement covering 200% of the shares issuable under the note by August 31, 2026, with effectiveness required by September 11, 2026.
- Dilution Risk: The lowered conversion price (70% of VWAP) and the issuance of warrants increase the potential for significant shareholder dilution.
- Cash Flow Pressure: The requirement to divert 90% of sales proceeds to debt service may constrain operational liquidity.
Investor Verification Checklist
- Verify the status of the stockholder approval vote scheduled for August 28, 2026.
- Confirm the filing and effectiveness date of the resale registration statement required by September 11, 2026.
- Assess the impact of the 90% sales proceeds diversion on the Company's ability to fund ongoing operations.
- Review the full text of Exhibits 10.1 and 10.2 for detailed covenants and default provisions.
- Monitor the Company's stock price volatility, as the conversion price and floor price are directly tied to the lowest VWAP over 20-day periods.